President Barack Obama’s deficit- trimming proposal would cut $320 billion from U.S. health programs in prescription drug and nursing home spending and by increasing individuals’ payments for Medicare coverage.
The biggest reduction is $135 billion in drug prices the government pays companies led by New York-based Pfizer Inc. (PFE) and Merck & Co. of Whitehouse Station, New Jersey, for low-income beneficiaries. The White House released its plan today.
http://www.bloomberg.com/news/2011-...n-health-cuts-targets-u-s-drug-purchases.html
Once PHrMA supported Obama National Healthcare, it signaled the beginning to an end of a once great innovative US industry.
The biggest reduction is $135 billion in drug prices the government pays companies led by New York-based Pfizer Inc. (PFE) and Merck & Co. of Whitehouse Station, New Jersey, for low-income beneficiaries. The White House released its plan today.
http://www.bloomberg.com/news/2011-...n-health-cuts-targets-u-s-drug-purchases.html
Once PHrMA supported Obama National Healthcare, it signaled the beginning to an end of a once great innovative US industry.